Market Formation in a Global Health Transition

Transition studies have started to focus on market formation in innovation systems. This article investigates market formation in a global health transition that was instigated by drug-resistant malaria. We explore how markets for Artemisinin-based Combination Therapies (ACT) in the Greater Mekong Subregion (GMS) were formed at multiple geographical scales and locations. The study reveals the role of public institutes, academia and partnerships in early innovation system development. It demonstrates how transnational organizations created a supportive global landscape for ACT development and deployment. It then reveals how these advancements led to the formation of public-sector and private-sector ACT markets in the GMS. We illustrate how market formation activities took place on global, national and local scales and how structural couplings enabled the functioning of this global innovation system. The lessons learned are particularly relevant now that drug-resistant malaria has once more emerged in the GMS, urgently calling for new therapies and associated end-user markets.

• Publication year

  2021

• Venue

  Environmental Innovation and Societal Transitions

• Publication date

  2021-09-01

• Fields of study

  Medicine, Business, Economics

• Identifiers
  DOI 10.1016/j.eist.2021.05.003PMID 35106274PMCID 7612298
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Deploying triple artemisinin-based combination therapy (TACT) for malaria treatment in Africa: ethical and practical considerations

  2021cited by this paper
• Shaping sustainable markets—A conceptual framework illustrated by the case of biogas in Sweden

  2020cited by this paper
• Understanding the protein transition: The rise of plant-based meat substitutes

  2020cited by this paper
• How product development partnerships support hybrid collaborations dealing with global health challenges

  2020cited by this paper
• Triple Artemisinin-Based Combination Therapies for Malaria - A New Paradigm?

  2020cited by this paper
• Market formation in the context of transitions: A comment on the transitions agenda

  2020cited by this paper
• The role of public procurement in the formation of markets for innovation

  2020cited by this paper
• Towards sustainable urban basic services in low-income countries: A Technological Innovation System analysis of sanitation value chains in Nairobi

  2019cited by this paper
• Rituximab versus steroids and cyclophosphamide for the treatment of primary membranous nephropathy: protocol of a pilot randomised controlled trial

  2019cited by this paper
• Role of knowledge and policies as drivers for low-energy housing: Case studies from the United Kingdom

  2019cited by this paper
• A retrospective analysis of responsible innovation for low-technology innovation in the Global South

  2019cited by this paper
• Capabilities for market-shaping: triggering and facilitating increased value creation

  2019cited by this paper
• Exploring global and country-level barriers to an effective supply of leishmaniasis medicines and diagnostics in eastern Africa: a qualitative study

  2019cited by this paper
• Triple artemisinin-containing combination anti-malarial treatments should be implemented now to delay the emergence of resistance

  2019cited by this paper
• The Creation and Evolution of the Donor Funded Market for Antimalarials and the Growing Role of Southern Firms

  2018cited by this paper
• Innovation intermediary challenging the energy incumbent: enactment of local socio-technical transition pathways by destabilisation of regime rules

  2018cited by this paper
• Technological Forecasting & Social Change Institutionalisation of markets: The case of personalised cancer medicine in the Netherlands

  2018influential reference
• Expanding malaria diagnosis and treatment in Lao PDR: lessons learned from a public–private mix initiative

  2017cited by this paper
• Energy Internet forums as acceleration phase transition intermediaries

  2017cited by this paper
• How to Contain Artemisinin- and Multidrug-Resistant Falciparum Malaria.

  2017cited by this paper
• A Systems Perspective on Markets: Toward a Research Agenda

  2017cited by this paper
• Antimalarial Drug Resistance: A Threat to Malaria Elimination.

  2017cited by this paper
• Global Innovation Systems—A conceptual framework for innovation dynamics in transnational contexts

  2017influential reference
• Private sector opportunities and threats to achieving malaria elimination in the Greater Mekong Subregion: results from malaria outlet surveys in Cambodia, the Lao PDR, Myanmar, and Thailand

  2017cited by this paper
• Private sector opportunities and threats to achieving malaria elimination in the Greater Mekong Subregion: results from malaria outlet surveys in Cambodia, the Lao PDR, Myanmar, and Thailand

  2017cited by this paper
• Health equity and migrants in the Greater Mekong Subregion

  2017cited by this paper
• Diabetes and pulmonary tuberculosis: a global overview with special focus on the situation in Asian countries with high TB-DM burden

  2017cited by this paper
• What happened to anti-malarial markets after the Affordable Medicines Facility-malaria pilot? Trends in ACT availability, price and market share from five African countries under continuation of the private sector co-payment mechanism

  2017cited by this paper
• Artemisinin anti-malarial drugs in China

  2016cited by this paper
• Malaria: Global progress 2000 – 2015 and future challenges

  2016cited by this paper
• Implementing a “free” tuberculosis (TB) care policy under the integrated model in Jiangsu, China: practices and costs in the real world

  2016cited by this paper
• Global Introduction of New Multidrug-Resistant Tuberculosis Drugs—Balancing Regulation with Urgent Patient Needs

  2016cited by this paper
• Dihydroartemisinin-piperaquine resistance in Plasmodium falciparum malaria in Cambodia: a multisite prospective cohort study.

  2016cited by this paper
• Evidence of successful malaria case management policy implementation in Cambodia: results from national ACTwatch outlet surveys

  2016influential reference
• The skin as an orchestrator of influenza immunity.

  2016cited by this paper
• Institutional power play in innovation systems: The case of Herceptin®

  2016cited by this paper
• What Can We Learn About the Processes of Regulation of Tuberculosis Medicines From the Experiences of Health Policy and System Actors in India, Tanzania, and Zambia?

  2016cited by this paper
• Health Product Supply Chains in Developing Countries: Diagnosis of the Root Causes of Underperformance and an Agenda for Reform

  2015cited by this paper
• Technological innovation systems in contexts: conceptualizing contextual structures and interaction dynamics

  2015cited by this paper
• The discovery of Qinghaosu (artemisinin) as an effective anti-malaria drug: A unique China story

  2015cited by this paper
• A Brief History of Qinghaosu

  2015cited by this paper
• Can medical products be developed on a non-profit basis? Exploring product development partnerships for neglected diseases

  2015cited by this paper
• The discovery of artemisinin and the Nobel Prize in Physiology or Medicine

  2015cited by this paper
• Artemisinin-based combination therapy in the treatment of uncomplicated malaria: review of recent regulatory experience at the European Medicines Agency

  2015cited by this paper
• Understanding Private Sector Antimalarial Distribution Chains: A Cross-Sectional Mixed Methods Study in Six Malaria-Endemic Countries

  2014cited by this paper
• Artemisinin resistance – modelling the potential human and economic costs

  2014cited by this paper
• A quiet revolution in global public health: The World Health Organization’s Prequalification of Medicines Programme

  2014cited by this paper
• Towards a sustainable system of drug development.

  2014cited by this paper
• The origins of antimalarial-drug resistance.

  2014cited by this paper
• The story of artesunate–mefloquine (ASMQ), innovative partnerships in drug development: case study

  2013cited by this paper
• Antimalarial drug resistance: a review of the biology and strategies to delay emergence and spread.

  2013cited by this paper
• Artemisinin-based combination therapy availability and use in the private sector of five AMFm phase 1 countries

  2013cited by this paper
• Ascaris co-infection does not alter malaria-induced anaemia in a cohort of Nigerian preschool children

  2013cited by this paper
• MMV in partnership: the Eurartesim® experience

  2013cited by this paper
• The Local Sources of Market Formation: Explaining Regional Growth Differentials in German Photovoltaic Markets

  2012influential reference
• Towards a spatial perspective on sustainability transitions

  2012cited by this paper
• Malaria in the Greater Mekong Subregion: heterogeneity and complexity.

  2012influential reference
• Places and Spaces of Sustainability Transitions: Geographical Contributions to an Emerging Research and Policy Field

  2012cited by this paper
• Market Formation in Technological Innovation Systems—Diffusion of Photovoltaic Applications in Germany

  2011influential reference
• Got ACTs? Availability, price, market share and provider knowledge of anti-malarial medicines in public and private sector outlets in six malaria-endemic countries

  2011cited by this paper
• The discovery of artemisinin (qinghaosu) and gifts from Chinese medicine

  2011cited by this paper
• From bark to weed: The history of artemisinin

  2011cited by this paper
• Socially-marketed rapid diagnostic tests and ACT in the private sector: ten years of experience in Cambodia

  2011cited by this paper
• Innovation Studies Utrecht ( ISU ) Working Paper Series Systemic instruments for systemic innovation problems : a framework for policy makers and innovation scholars

  2011cited by this paper
• Innovative public-private partnerships to maximize the delivery of anti-malarial medicines: lessons learned from the ASAQ Winthrop experience

  2011cited by this paper
• Sex work and the 2010 FIFA World Cup: time for public health imperatives to prevail

  2010cited by this paper
• Open Access RESEARCH

  2010cited by this paper
• How New Market Categories Emerge: Temporal Dynamics of Legitimacy, Identity, and Entrepreneurship in Satellite Radio, 1990–2005

  2010cited by this paper
• Discovery, mechanisms of action and combination therapy of artemisinin

  2009cited by this paper
• Discovery of Artemisinin (Qinghaosu)

  2009cited by this paper
• Countering Drug Resistance in the Developing World: An Assessment of Incentives Across the Value Chain and Recommendations for Policy Intervention

  2009cited by this paper
• Artemisinin resistance in Plasmodium falciparum malaria.

  2009cited by this paper
• Constructing Markets and Shaping Boundaries: Entrepreneurial Power in Nascent Fields

  2009cited by this paper
• Motors of sustainable innovation

  2009cited by this paper
• Access to artemisinin combination therapy for malaria in remote areas of Cambodia

  2008cited by this paper
• Analyzing the functional dynamics of technological innovation systems: A scheme of analysis

  2008cited by this paper
• A major transition in malaria treatment: the adoption and deployment of artemisinin-based combination therapies.

  2007cited by this paper
• The Sociology of Markets

  2007cited by this paper
• Functions of innovation systems: A new approach for analysing technological change

  2007cited by this paper
• The Major Role of Clinicians in the Discovery of Off‐Label Drug Therapies

  2006cited by this paper
• Manslaughter by Fake Artesunate in Asia—Will Africa Be Next?

  2006cited by this paper
• Role of US military research programs in the development of US Food and Drug Administration--approved antimalarial drugs.

  2006cited by this paper
• The Coartem Challenge (A)

  2006cited by this paper
• The process of changing national malaria treatment policy: lessons from country-level studies.

  2004cited by this paper
• The origins of antimalarial drug resistance.

  2004cited by this paper
• Fake antimalarials in Southeast Asia are a major impediment to malaria control: multinational cross‐sectional survey on the prevalence of fake antimalarials

  2004cited by this paper
• Saving lives, buying time : economics of malaria drugs in an age of resistance

  2004influential reference
• Combination therapy for malaria: the way forward?

  2002cited by this paper
• The public health impact of chloroquine resistance in Africa.

  2001cited by this paper
• Antimalarial drug resistance and combination chemotherapy.

  1999cited by this paper
• Systems of Innovation: Technologies, Institutions and Organizations

  1997cited by this paper
• Artesunate versus artemether in combination with mefloquine for the treatment of multidrug-resistant falciparum malaria.

  1995cited by this paper
• Single day mefloquine-artesunate combination in the treatment of multi-drug resistant falciparum malaria.

  1994cited by this paper
• Qinghaosu

  1993cited by this paper
• Qinghaosu.

  1993cited by this paper
• Randomised trial of artesunate and mefloquine alone and in sequence for acute uncomplicated falciparum malaria.

  1992cited by this paper
• Randomised comparative study of mefloquine, qinghaosu, and pyrimethamine-sulfadoxine in patients with falciparum malaria.

  1984cited by this paper
• ANTIMALARIAL ACTIVITY OF MEFLOQUINE AND QINGHAOSU

  1982cited by this paper
• Antimalarial activity of mefloquine and qinghaosu.

  1982cited by this paper
• Antimalaria studies on Qinghaosu.

  1979cited by this paper

• One Health and Antimicrobial resistance in Somalia: Policy Insights from Centennial Vision 2060

  2026cites this paper
• The dynamics of a global innovation system: green methanol as a marine transportation fuel

  2025cites this paper
• The geography of eco-innovations and sustainability transitions: A systematic comparison

  2024cites this paper
• The Art of State-Societal Reconfiguration in a Time of Pandemic Crisis: A Health System Resilience Typology and Comparative Analysis Between Transcending Nations (the US, UK, and India) and Coping Nations (South Korea and Taiwan)

  2024cites this paper
• Evaluation of Segmentation, Rotation, and Geographic Delivery Approaches for Deployment of Multiple First-Line Treatment (MFT) to Respond to Antimalarial Drug Resistance in Africa: A Qualitative Study in Seven Sub-Sahara Countries

  2024cites this paper
• A framework for stakeholder engagement in the adoption of new anti-malarial treatments in Africa: a case study of Nigeria

  2023cites this paper
• An elephant in the glasshouse? Trade-offs between acceleration and transformation in COVID-19 vaccine innovation policies

  2023cites this paper
• Strategies for deploying triple artemisinin-based combination therapy in the Greater Mekong Subregion

  2023cites this paper
• Exploring the feasibility of introducing triple artemisinin-based combination therapy in the malaria treatment policy in Vietnam

  2023cites this paper
• The role of governments in uncertainty orchestration in market formation for sustainability transitions

  2022cites this paper
• Expert perspectives on the introduction of Triple Artemisinin-based Combination Therapies (TACTs) in Southeast Asia: a Delphi study

  2022influential citation
• 'Selling the monster' or the relevance of cultural-cognitive conditions in creating demand for innovation: the case of COVID-19 vaccines and beyond

  2022cites this paper
• Geography of eco-innovations vis-à-vis geography of sustainability transitions: Two sides of the same coin? Geography of eco-innovations vis-à-vis geography of sustainability transitions: Two sides of the same coin?

  2021cites this paper
• To what extent are the antimalarial markets in African countries ready for a transition to triple artemisinin-based combination therapies?

  2021cites this paper
• The impact of supply structure on solar home system installations in rural off-grid areas

  2021cites this paper
• International organisations in global sustainability transitions

  2021cites this paper